As seen in the DESTINY-Breast06 trial, a pproximately 20-25 percent of hormone receptor (HR)-positive, HER2-negative breast cancer patients may be considered HER2-ultralow.1 These patients may now be ...

Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory for Digestive Health, National Clinical Research Center for Digestive Disease, Beijing ...

By analyzing ERBB2 mRNA expression data, researchers identified a group of HER2-negative patients with poor outcomes and potential markers of treatment resistance.

The company will refinance a term loan worth $500 million and revolving facility for $750 million maturing in Oct. 2025, CFO ...

Roche has announced that the FDA has expanded the approval of its PATHWAY® HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test to identify HE ...

patients identified by the AI model as having a high proportion of HER2 IHC 3+ tumour cells exhibited better clinical outcomes than those identified through traditional HER2 evaluation methods.

Oxytocin receptor (Oxtr) signaling influences complex social behaviors in diverse species, including social monogamy in prairie voles. How Oxtr regulates specific components of social attachment ...

neoadjuvant or adjuvant CRTx followed by surgery); tissue specimen type (surgical specimen vs endoscopic biopsy); TP53 assay methods (TP53 gene sequencing, single-strand confirmation polymorphism ...

were analyzed using the Kaplan–Meier method and Cox proportional hazards model. The expression of the tumor angiogenesis marker CD31 and stroma-related protein CTHRC1 were analyzed using ...

The year 2015 marked the inception of Sanyou Bio's technological journey, laying the foundation for its core technology platform. The R&D team devoted itself to the development of display vectors, ...

ADNOC Drilling, a unit of the United Arab Emirates' state oil giant, is looking to refinance debt maturing later this year ...